Page 107 - Annual report 2021-22
P. 107
Annual Report 2021-22 |
in the Sirohi district of Rajasthan. However, the high rates of Tuberculosis in this region make diagnosis
of silicos and prioritization of treatment difficult. Towards overcoming this challenge, Vivek Rao’s lab
is involved in establishing a prospective cohort of silicosis, TB, silico-TB patients in Sirohi Rajasthan.
The study aims to establish blood/PBMC based gene expression signatures of these lung diseases.
Vivek Rao and Sheetal Gandotra’s lab standardized protocols for T cell immune monitoring for
90
COVID19 infection and vaccination which will be used for a pan-CSIR T cell monitoring study for
COVID19.
“A totally blind process can by definition lead to anything; it can even
lead to vision itself.” — Jacques Monod
